CTOs on the Move

Multi Media Communications

www.mmcom.com

 
Multi Media Communications is a Las Vegas, NM-based company in the Software and Internet sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mmcom.com
  • 81 Aspen
    Las Vegas, NM USA 87701
  • Phone: 480.422.1645

Executives

Name Title Contact Details

Similar Companies

Thunderbird

Thunderbird is a free email application that’s easy to set up and customize - and it’s loaded with great features!

Findly

Findly leads the world in talent innovation as the creator of On Demand Talent, the ability for employers to instantly get the right talent. Findly’s award-winning solutions combine unrivaled mobile and social capabilities, employer brand strategy, creative, digital and media placement with applicant tracking and assessments to address the challenge of finding the right talent at the push of a button.  Built for today’s digitally savvy and highly mobile workforce, Findly delivers a compelling automated talent platform that uses a hierarchical methodology with focused employer branding campaigns to acquire, manage, screen and engage only warm candidates. The result is a more strategic use of talent and enhanced competitive advantage.

System1

System1 was founded in Venice, CA with a simple mission - use technology to make advertising better for consumers and advertisers. System1 is led by a team of passionate and experienced entrepreneurs who have built multiple billion dollar companies.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.